Creative Planning Bruker Corp Transaction History

Creative Planning

$129 Billion
Q3 2025

A detailed history of Creative Planning transactions in Bruker Corp stock. As of the latest transaction made, Creative Planning holds 8,987 shares of BRKR stock, worth $374,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,987

Previous 16,663 46.07%

Holding current value

$374,038

Previous $686,000 57.58%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$29.35 - $43.93 $225,290 - $337,206	-7,676 Reduced 46.07%	8,987 $291,000
Q2 2025 Aug 08, 2025	BUY	$35.5 - $42.18 $147,893 - $175,721	4,166 Added 33.34%	16,663 $686,000
Q1 2025 May 15, 2025	BUY	$41.74 - $62.95 $77,093 - $116,268	1,847 Added 17.34%	12,497 $521,000
Q4 2024 Feb 14, 2025	SELL	$48.25 - $67.46 $48,539 - $67,864	-1,006 Reduced 8.63%	10,650 $624,000
Q3 2024 Oct 11, 2024	SELL	$60.3 - $70.67 $25,929 - $30,388	-430 Reduced 3.56%	11,656 $804,000

Q2 2024 Aug 15, 2024	SELL	$63.57 - $92.93 $5,212 - $7,620	-82 Reduced 0.67%	12,086 $771,000
Q1 2024 May 10, 2024	BUY	$69.21 - $94.27 $374,564 - $510,189	5,412 Added 80.11%	12,168 $1.14 Million
Q4 2023 Feb 14, 2024	BUY	$54.91 - $74.64 $158,360 - $215,261	2,884 Added 74.48%	6,756 $496,000
Q3 2023 Nov 16, 2023	SELL	$61.34 - $75.77 $37,172 - $45,916	-606 Reduced 13.53%	3,872 $241,000
Q2 2023 Jul 21, 2023	BUY	$69.1 - $84.02 $56,938 - $69,232	824 Added 22.55%	4,478 $331,000
Q1 2023 May 15, 2023	BUY	$65.49 - $78.84 $18,861 - $22,705	288 Added 8.56%	3,654 $288,000
Q4 2022 Feb 10, 2023	BUY	$54.36 - $69.91 $182,975 - $235,317	3,366 New	3,366 $230,000

Others Institutions Holding BRKR

# of Institutions

380

Shares Held

118M

Call Options Held

543K

Put Options Held

488K

View Full List

About BRUKER CORP

Ticker BRKR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 148,138,000
Market Cap $6.17B
Description
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...

More about BRKR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Bruker Corp Transaction History